The a2 Milk Company Limited (ASX:A2M)
| Market Cap | 4.10B -31.0% |
| Revenue (ttm) | 1.77B +21.1% |
| Net Income | 105.30M -29.9% |
| EPS | 0.14 -29.9% |
| Shares Out | n/a |
| PE Ratio | 38.98 |
| Forward PE | 22.15 |
| Dividend | 0.19 (3.21%) |
| Ex-Dividend Date | Mar 19, 2026 |
| Volume | 2,565,958 |
| Average Volume | 3,455,536 |
| Open | 5.65 |
| Previous Close | 5.61 |
| Day's Range | 5.63 - 5.77 |
| 52-Week Range | 5.58 - 9.97 |
| Beta | 0.29 |
| RSI | 18.44 |
| Earnings Date | Aug 15, 2026 |
About The a2 Milk Company
The a2 Milk Company Limited, together with its subsidiaries, sells A2-type protein type branded milk and related products in Australia, New Zealand, China, rest of Asia, and the United States. The company offers infant milk formula; other nutritional products and milk; manufactures and sells nutritional and ingredients products, as well as provides rent, royalty, and licensing services. It offers its products under the a2 Milk and a2 Platinum brands. The company was formerly known as A2 Corporation Limited and changed its name to The a2 Milk Co... [Read more]
Financial Performance
In fiscal year 2025, The a2 Milk Company's revenue was 1.90 billion, an increase of 13.50% compared to the previous year's 1.67 billion. Earnings were 202.89 million, an increase of 21.07%.
Financial numbers in NZD Financial StatementsNews
a2 Milk Recalls 63,078 Formula Tins As Shares Drop 19%
a2 Milk Recalls 63,078 Formula Tins As Shares Drop 19%
a2 Milk product recall hammers shares; Chalmers plays down tax cuts; Buffett’s bet against AI is a warning
Read everything that’s happened in the news so far today.
a2 Milk forced to recall contaminated infant formula, shares slump
The Auckland-headquartered, Australian-listed dairy products manufacturer said it would voluntarily recall batches of product exported to the US last year.
a2 Milk (ACOPF) Issues Recall for Infant Formula Due to Toxin Contamination
a2 Milk (ACOPF) Issues Recall for Infant Formula Due to Toxin Contamination
The a2 Milk Company Earnings Call Transcript: H1 2026
Delivered strong double-digit revenue and EBITDA growth, driven by core products and innovation across all regions. Upgraded FY 2026 guidance to mid double-digit revenue growth and tightened EBITDA margin range, with continued market share gains in China and new product launches supporting future growth.
The a2 Milk Company Quarterly report: H1 2026
The a2 Milk Company has published its H1 2026 quarterly earnings report on February 15, 2026.
The a2 Milk Company Slides: H1 2026
The a2 Milk Company has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 15, 2026.
The a2 Milk Company Earnings Call Transcript: H1 2026
Delivered strong double-digit revenue and EBITDA growth, driven by core products and innovation across all regions. Upgraded FY 2026 guidance to mid double-digit revenue growth and tightened EBITDA margin range, with continued market share gains in China and new product launches supporting future growth.
The a2 Milk Company Quarterly report: H1 2026
The a2 Milk Company has published its H1 2026 quarterly earnings report on February 15, 2026.
The a2 Milk Company Slides: H1 2026
The a2 Milk Company has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 15, 2026.
The a2 Milk Company Transcript: AGM 2025
Shareholders heard of strong FY 2025 results, with 13.5% revenue growth and major supply chain transformation, including a new manufacturing facility and expanded China market access. Dividend payouts increased, new directors were elected, and strategic initiatives in innovation, sustainability, and emerging markets were highlighted.
The a2 Milk Company Slides: FY 2025
The a2 Milk Company has posted slides in relation to its FY 2025 quarterly earnings report, which was published on November 19, 2025.
The a2 Milk Company Transcript: AGM 2025
Shareholders heard of strong FY 2025 results, with 13.5% revenue growth and major supply chain transformation, including a new manufacturing facility and expanded China market access. Dividend payouts increased, new directors were elected, and strategic initiatives in innovation, sustainability, and emerging markets were highlighted.
The a2 Milk Company Slides: FY 2025
The a2 Milk Company has posted slides in relation to its FY 2025 quarterly earnings report, which was published on November 19, 2025.
The a2 Milk Company Earnings Call Transcript: H2 2025
Record FY 2025 results with NZD 1.9B sales, 13.5% revenue growth, and strong China/Asia performance. Major supply chain transformation announced, including Yashili NZ acquisition and MVM divestment, with high single-digit revenue growth and 15%-16% EBITDA margin targeted for FY 2026.
The a2 Milk Company Slides: H2 2025
The a2 Milk Company has posted slides in relation to its H2 2025 quarterly earnings report, which was published on August 17, 2025.
The a2 Milk Company Annual report: H2 2025
The a2 Milk Company has published its H2 2025 annual report on August 17, 2025.
The a2 Milk Company Earnings Call Transcript: H2 2025
Record FY 2025 results with NZD 1.9B sales, 13.5% revenue growth, and strong China/Asia performance. Major supply chain transformation announced, including Yashili NZ acquisition and MVM divestment, with high single-digit revenue growth and 15%-16% EBITDA margin targeted for FY 2026.
The a2 Milk Company Slides: H2 2025
The a2 Milk Company has posted slides in relation to its H2 2025 quarterly earnings report, which was published on August 17, 2025.
The a2 Milk Company Annual report: H2 2025
The a2 Milk Company has published its H2 2025 annual report on August 17, 2025.
A2 Milk Company upgraded to Outperform from Neutral at Macquarie
Macquarie upgraded A2 Milk Company (ACOPF) to Outperform from Neutral with a price target of A$7.85, up from A$5.70. The market is “still tough,” but early-stage performance is “encouraging” as…